Retrospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4218-4225
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4218
Table 1 Baseline characteristics and prognoses of patients with rhabdomyolysis induced by community-acquired pneumonia
CaseAge(yr)SexDiagnosisBMIMaximum temperature (°C)SymptomsAKIHospitalstay (d)OutcomePSI
152MaleCAP24.541.0Tiredness, myalgia sometimesNo11Cured67
265MaleSCAP20.339.3Soy urine hypourocriniaYes25Cured105
356MaleCAP21.739.4HypourocriniaYes14Cured66
422MaleCAP27.840.0TiredYes7Cured37
532MaleSCAP33.940.6Myalgia, tirednessNo23Cured67
672MaleSCAP20.339.7NoneNo3Died112
786MaleCAP19.538.3HypourocriniaYes18Cured86
884MaleSCAP-40.7NoneYes44Cured99
976MaleSCAP-40.5NoneYes18Died161
1081MaleCAP21.538.9Myalgia, tirednessNo11Cured131
1148MaleCAP21.237.3Soy urine, myalgiaYes8Cured48
Table 2 Comparison of baseline characteristics and prognosis in patients with rhabdomyolysis induced by community-acquired pneumonia and by exercise
Age (yr)SexBMIMaximum temperature (°C)AKIHospital stay (d)Outcome
CAP (n = 11)61.27 ± 21.34Male 11 Female 023.41 ± 6.7039.7 (38.9,40.6)7 (63.63%)16.55 ± 11.34Cured 9 Died 2
Exercise(n = 48)23.29 ± 8.06Male 43 Female 525.02 ± 4.1536.9 (36.8, 37.0)8 (16.67%)9.83 ± 3.83Cured 48 Died 0
F/Z/X227.381.250.15-5.0310.4113.969.03
P< 0.05> 0.05> 0.05< 0.05< 0.05< 0.05< 0.05
Table 3 Test parameters of patients with rhabdomyolysis induced by community-acquired pneumonia
ParametersCase 1Case 2Case 3Case 4Case 5Case 6Case 7Case 8Case 9Case 10Case 11
WBC (3.9-9.7 × 109/L)7.29.214.23.96.116.111.411.09.387.612.0
CRP (0-8 mg/L)12131831120.620.834027710037.11425.4
PCT (< 0.05 ng/mL)0.28511.498.820.262.174.720.2350.4180.170.1820.071
pH (7.35-7.45)7.4207.4807.4467.4057.4567.4607.4677.407.4507.4237.450
PaCO2 (35-45 mmHg)383134.835.230.230.137.6373035.940
PaO2 (80-100 mmHg)836986.784.257.551.962.5876864.676
HCO3-(AB) (22-27 mmol/L)24.223.124.821.626.222.926.822.920.923.027.8
CKmax (29-200 U/L)11470104866275.62489.314090.41007.31301.81651160001888.681402
Mbmax (0-105.7 μg/L)975.51176.51021.6314.63277.3243.3456.4-3804564.23804
Peak days55567567496
SCr (45-84 μmol/L)73159.6268.9111.3105.893.761.9129.2130.7102.653
BUN (2.5-7.2 mmol/L)3.3113.0214.345.164.858.127.8610.5518.6911.126.44
K+ (3.5-5.5 mmol/L)3.093.563.534.023.03.453.633.744.113.814.75
CTnI (0-0.04 μg/L)0.060.360.060.010.070.070.040.161.5620.030.00
AST (5-34 U/L)38393921198819593072132961586.7
ALT (0-40 U/L)1674874771342622532250989.8
LDH (125-243 U/L)1072151937346017113682334372625326834
Table 4 Comparison of test parameters in patients with rhabdomyolysis induced by community-acquired pneumonia and by exercise
ParametersCAP (n = 11)Exercise (n = 48)F/Z/X2P value
WBC (3.9-9.7 × 109/L)9.83 ± 3.598.97 ± 2.891.40> 0.05
CRP (0-8 mg/L)153.90 ± 132.937.90 ± 5.60157.79< 0.05
pH (7.35-7.45)7.44 ± 0.037.39 ± 0.041.34< 0.05
Oxygenation index (mmHg)304.60 ± 76.89436.64 ± 38.843.72< 0.05
CKmax (29-200 U/L)6275.60 (1651.00, 14090.40)60300.00 (16240.75, 89531.75)-4.29< 0.05
Mbmax (0-105.7 μg/L)998.55 (420.95, 3408.98)3809.30 (2643.65, 3934.25)-3.01< 0.05
Peak days6 (5, 7)4 (3, 5)-3.83< 0.05
SCr (45-84 μmol/L)105.80 (73.00, 130.70)68.10 (62.25, 80.07)-2.66< 0.05
BUN (2.5-7.2 mmol/L)8.12 (5.16, 13.02)4.06 (3.31, 4.76)-3.76< 0.05
K+ (3.5-5.5 mmol/L)3.70 ± 0.494.12 ± 0.321.57< 0.05
AST (5-34 U/L)98 (59, 819)1360 (909.5, 1819.15)-3.10< 0.05
ALT (0-40 U/L)53 (22, 134)354 (246, 444)-3.03< 0.05
LDH (125-243 U/L)460 (368, 1519)2177 (1069.5, 3130)-3.15< 0.05